X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16) 16
male (13) 13
female (12) 12
aged (9) 9
index medicus (9) 9
middle aged (9) 9
adult (6) 6
rheumatology (6) 6
infectious diseases (5) 5
rheumatoid arthritis (5) 5
stroke (5) 5
abridged index medicus (4) 4
cardiovascular disease (4) 4
cardiovascular diseases (4) 4
cardiovascular diseases - mortality (4) 4
clinical medicine (4) 4
double-blind method (4) 4
drug therapy (4) 4
health risk assessment (4) 4
heart attacks (4) 4
immunology (4) 4
medicine, general & internal (4) 4
myocardial infarction (4) 4
acute coronary syndromes (3) 3
care and treatment (3) 3
clinical trials (3) 3
diagnosis (3) 3
disease prevention (3) 3
dose-response relationship (3) 3
dose-response relationship, drug (3) 3
epidemiology (3) 3
infliximab (3) 3
klinisk medicin (3) 3
microparticles (3) 3
myocardial infarction - prevention & control (3) 3
research (3) 3
rheumatoid-arthritis (3) 3
risk factors (3) 3
stroke - prevention & control (3) 3
adalimumab (2) 2
administration & dosage (2) 2
adverse effects (2) 2
american-college (2) 2
angina (2) 2
angina pectoris (2) 2
antibodies, monoclonal - adverse effects (2) 2
anticoagulants (2) 2
antiretroviral therapy (2) 2
arthritis (2) 2
arthritis, rheumatoid - drug therapy (2) 2
aspirin (2) 2
aspirin - administration & dosage (2) 2
aspirin - adverse effects (2) 2
aspirin - therapeutic use (2) 2
blood (2) 2
cardiovascular diseases - prevention & control (2) 2
cerebral infarction (2) 2
chemically induced (2) 2
classification (2) 2
colombia (2) 2
combination (2) 2
coronary vessels (2) 2
cross-sectional studies (2) 2
dendritic cells (2) 2
dermatomyositis (2) 2
diagnosis, differential (2) 2
disease (2) 2
disease control (2) 2
drug (2) 2
drug administration schedule (2) 2
drug dosages (2) 2
drug therapy, combination (2) 2
engineering, multidisciplinary (2) 2
etanercept (2) 2
evidence-based medicine (2) 2
factor xa inhibitors (2) 2
factor xa inhibitors - administration & dosage (2) 2
factor xa inhibitors - adverse effects (2) 2
factor xa inhibitors - therapeutic use (2) 2
health aspects (2) 2
hemorrhage (2) 2
hemorrhage - chemically induced (2) 2
highly active (2) 2
hiv (2) 2
hypothyroidism (2) 2
immune complexes (2) 2
incidence (2) 2
infections (2) 2
inflammation (2) 2
life sciences (2) 2
macrophages (2) 2
metabolic diseases (2) 2
morbidity (2) 2
mortality (2) 2
myocardial infarction - drug therapy (2) 2
myocardial infarction - epidemiology (2) 2
myocardial-infarction (2) 2
platelet aggregation inhibitors (2) 2
platelet aggregation inhibitors - administration & dosage (2) 2
platelet aggregation inhibitors - adverse effects (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Diaz, Rafael and Widimsky, Peter and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Keltai, Katalin and Maggioni, Aldo P and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Pogosova, Nana and Ryden, Lars and Fox, Keith A A and Bhatt, Deepak L and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Avezum, Alvaro A and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ZIMMERMANN, SERGIO LUIZ and ... and COMPASS Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | THERAPY | OUTPATIENTS | CARDIOVASCULAR EVENT RATES | PREVENTION | RISK | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Evidence-based medicine | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment | Cardiovascular Diseases | Factor Xa Inhibitors | Klinisk medicin | Hemorrhage | epidemiology | Rivaroxaban | administration & dosage | Combination | Amputation | Drug | drug therapy | chemically induced | complications | prevention & control | Peripheral Arterial Disease | etiology | Clinical Medicine | Myocardial Infarction | statistics & numerical data | blood supply | Carotid Artery Diseases | Platelet Aggregation Inhibitors | adverse effects | mortality | Lower Extremity | Dose-Response Relationship | therapeutic use | surgery
Journal Article
by Connolly, Stuart J and Eikelboom, John W and Bosch, Jackie and Dagenais, Gilles and Dyal, Leanne and Lanas, Fernando and Metsarinne, Kaj and O'Donnell, Martin and Dans, Anthony L and Ha, Jong-Won and Parkhomenko, Alexandr N and Avezum, Alvaro A and Lonn, Eva and Lisheng, Liu and Torp-Pedersen, Christian and Widimsky, Petr and Maggioni, Aldo P and Felix, Camilo and Keltai, Katalin and Hori, Masatsugu and Yusoff, Khalid and Guzik, Tomasz J and Bhatt, Deepak L and Branch, Kelley R H and Cook Bruns, Nancy and Berkowitz, Scott D and Anand, Sonia S and Varigos, John D and Fox, Keith A A and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ZIMMERMANN, SERGIO LUIZ and RECH, RAFAEL and ABIB JR, EDUARDO and ... and COMPASS investigators and COMPASS Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 205 - 218
Coronary artery disease is a major cause of morbidity and mortality worldwide, and is a consequence of acute thrombotic events involving activation of... 
PREVENTION | MEDICINE, GENERAL & INTERNAL | ORAL RIVAROXABAN | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Male | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Coronary Artery Disease - drug therapy | Morbidity | Factor Xa Inhibitors - therapeutic use | Factor Xa Inhibitors - adverse effects | Aged | Coronary Artery Disease - epidemiology | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Anticoagulants | Aspirin | Stroke | Heart attacks | Mortality | Coronary artery | Clinical trials | Cardiovascular disease | Coronary artery disease | Disease control | Evidence-based medicine | Disease prevention | Coronary vessels | Acute coronary syndromes | Thromboembolism | Health risk assessment | Drug therapy | Heart diseases | Cardiovascular Diseases | Factor Xa Inhibitors | Klinisk medicin | Hemorrhage | epidemiology | Rivaroxaban | administration & dosage | Combination | Drug | drug therapy | chemically induced | prevention & control | Coronary Artery Disease | Clinical Medicine | Myocardial Infarction | Platelet Aggregation Inhibitors | adverse effects | mortality | Dose-Response Relationship | therapeutic use
Journal Article
by Gomez-Reino, Juan J and Carmona, Loreto and Erra, Alba and Marsal, Sara and Castro, Mónica Fernández and Mulero, Juan and Andreu, Jose Luis and Gómez, Manuel Rodríguez and Padro, Marta Larrosa and Casado, Enrique and Leonor, Elena and Alierta, Sirvent and Reina, Delia and Gómez, Carmen García and Ibañez, Beatriz Joven and Delgado, Patricia Carreira and Hernández, Ma. Victoria and Loza, Estibaliz and Ruiz, Alberto Alonso and Itzazelaia, Esther Uriarte and Zarza, Lucia Pantoja and Aransay, Ma. Valvanera Pinillos and Hernández, Teresa Mariné and de Vicuña Pinedo, Rosario García and García, Ana Ma. Ortiz and Álvaro, Isidoro González and Laffon, Armando and Álvaro-Gracia, Jose Ma and López, César Díaz and de La Serna, Arturo Rodríguez and Cortina, Eduardo Loza and Oyarzabal, Ma. Victoria Irigoyen and Garnica, Inmaculada Ureña and Cagigal, Virginia Coret and Casasempere, Paloma Vela and Pascual, Eliseo and Serrano, Miquel Ángel Belmonte and Fabregat, Juan Beltran and Lerma, Juan José and Graña, Myriam Liz and Gómez-Reino, Juan José and Aizen, Saul Mario Gelman and Monge, Elena Ciruelo and Muriel, Eva Tomero and García, Juan Carlos Cobeta and Cuenca, Encarnación Saiz and Muñoz, José Galvez and de La Torre, Gerardo Iglesias and Pardo, Rosa Roselló and Galeano, Carlos Vázquez and de Diego, Juan Pablo Valdazo and Marsá, Xavier Tena and Santamaría, Vera Ortiz and Prada, Manuel Fernández and Piqueras, José Antonio and Tornero, Jesús and Méndez, Laura Cebrián and Carreño, Luis and Borras, Juan José García and Ruiz, Francisco Javier Manero and Busquets, Manel Pujol and Duran, Josep Granados and Cuadra, Jose Luis and Tevar, F. Javier Paulino and Huertas, Marcos Paulino and Maiz, Olga and Barastay, Estibaliz and Figueroa, Manuel and Torres, Carmen and Coro, Montserrat Corteguera and Lozano, Carlos Rodríguez and Hernández, Félix Francisco and Fernández, Iñigo Rua Figueroa and Martín, Oscar Illera and Zea Mendoza, Antonio C and de La Peña Lefebvre, Paloma García and Expósito, Marta Valero and Aznar, Emilia and Gutiérrez, Ricardo and Valenciano, Ana Cruz and Echeverria, Manuel Crespo and Del Pozo, Félix Cabero and Jimeno, Ma. Teresa Ruiz and Aresté, Jordi Fiter and Poch, Luis Espadaler and Carasa, Juan Carlos Vesga and Quintana, Eduardo Cuende and Andrada, Sagrario Sánchez and Valverde, Vicente Rodríguez and Amaro, Ivan Ferraz and García, Tomas González and Marenco, José Luis and Rejón, Eduardo and Estevez, Eduardo Collantes and Castro Villegas, M. Carmen and Hernández, Blanca and de Oca Mercader, José V. Montes and Sarabia, Federico Navarro and de Miera, Francisco Javier Toyos Saenz and Fernández-Cid, Carlos Marras and ... and BIOBADASER Grp and BIOBADASER Group
Arthritis Research and Therapy, ISSN 1478-6354, 01/2006, Volume 8, Issue 1, pp. R29 - R29
Journal Article